Familial Alzheimer-like prion disease

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:280397A81.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial Alzheimer-like prion disease (Orphanet code 280397) is an extremely rare inherited prion disease (transmissible spongiform encephalopathy) caused by mutations in the PRNP gene, which encodes the prion protein. Unlike typical Alzheimer disease, this condition is classified among prion diseases, but it presents with clinical and neuropathological features that closely mimic Alzheimer disease, including progressive dementia, memory loss, and cognitive decline. The brain is the primary organ affected, with neurodegeneration characterized by spongiform changes, neuronal loss, and the accumulation of abnormal prion protein. Notably, affected individuals may also show amyloid plaques and neurofibrillary tangles reminiscent of Alzheimer disease, which can complicate the clinical and pathological distinction between the two conditions. The disease follows an autosomal dominant inheritance pattern, meaning that a single copy of the mutated PRNP gene inherited from an affected parent is sufficient to cause the condition. Onset typically occurs in adulthood, and the disease is progressive, leading to severe cognitive impairment, behavioral changes, and eventually death. Additional neurological features may include myoclonus, ataxia, and psychiatric symptoms such as depression or personality changes. Diagnosis is supported by genetic testing for PRNP mutations, neuroimaging, and cerebrospinal fluid biomarkers, though definitive diagnosis may require neuropathological examination. There is currently no cure or disease-modifying treatment for familial Alzheimer-like prion disease. Management is supportive and symptomatic, focusing on maintaining quality of life, managing behavioral and psychiatric symptoms, and providing palliative care as the disease progresses. Genetic counseling is recommended for affected families to discuss the implications of autosomal dominant inheritance and the availability of predictive genetic testing for at-risk relatives.

Clinical phenotype terms— hover any for plain English:

Deficit in phonologic short-term memoryHP:0002549Abdominal symptomHP:0011458Perseverative thoughtHP:0030223Jaw painHP:0040264
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Familial Alzheimer-like prion disease.

View clinical trials →

No actively recruiting trials found for Familial Alzheimer-like prion disease at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Familial Alzheimer-like prion disease community →

No specialists are currently listed for Familial Alzheimer-like prion disease.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Familial Alzheimer-like prion disease.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Familial Alzheimer-like prion diseaseForum →

No community posts yet. Be the first to share your experience with Familial Alzheimer-like prion disease.

Start the conversation →

Latest news about Familial Alzheimer-like prion disease

No recent news articles for Familial Alzheimer-like prion disease.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Familial Alzheimer-like prion disease

What is Familial Alzheimer-like prion disease?

Familial Alzheimer-like prion disease (Orphanet code 280397) is an extremely rare inherited prion disease (transmissible spongiform encephalopathy) caused by mutations in the PRNP gene, which encodes the prion protein. Unlike typical Alzheimer disease, this condition is classified among prion diseases, but it presents with clinical and neuropathological features that closely mimic Alzheimer disease, including progressive dementia, memory loss, and cognitive decline. The brain is the primary organ affected, with neurodegeneration characterized by spongiform changes, neuronal loss, and the accum

How is Familial Alzheimer-like prion disease inherited?

Familial Alzheimer-like prion disease follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Familial Alzheimer-like prion disease typically begin?

Typical onset of Familial Alzheimer-like prion disease is adult. Age of onset can vary across affected individuals.